Printer Friendly

HIV in breast milk can be drug resistant. (Virology).

A drug called nevirapine, sold as Viramune, can reduce the risk of mother-to-newborn transmission of HIV when taken by a woman at the onset of labor. Scientists now report that after taking nevirapine, the women often harbor a form of HIV with genetic mutations that make it resistant to the drug. Moreover, the mutant virus is more prevalent in the breast milk of infected women than in their blood.

The finding suggests that these women could be passing along resistant forms of the virus to their children during breast-feeding, says Esther Lee of Stanford University. HIV-infected mothers who choose to breastfeed have about a one-in-six chance of transmitting the virus to their babies via breast milk.

Lee and her colleagues analyzed blood and breast-milk samples from 20 nursing mothers in Zimbabwe who had received nevirapine when they went into labor. Thirteen of the women harbored nevirapine-resistant HIV in their breast milk, and eight of the women had these mutant viruses in their blood, Lee says. The samples were taken 2 and 8 weeks after birth.

Lee says that she and her colleagues expect to conduct a new study to determine how long the resistant HIV versions persist in the women.--N.S.
COPYRIGHT 2003 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Esther Lee of Stanford University
Publication:Science News
Article Type:Brief Article
Geographic Code:1USA
Date:Mar 1, 2003
Previous Article:Designer RNA stalls hepatitis in mice. (Microbiology).
Next Article:Good taste in men linked to colon risks. (Biology).

Related Articles
HIV may spare cells - for a short time.
A Study of Breastfeeding and HIV.
Can interrupting their treatment benefit HIV-infected people?
Superinfection (Reinfection): New Study in San Francisco Offers Free Resistance and Viral Load Testing.
Antibodies and HIV: New Evidence Interview with Ruth Ruprecht, M.D., Ph.D.
Retroviruses conference: Some new drugs in the pipeline.
Antiretroviral pipeline: new-drug reports from retroviruses conference.
Striking a better bargain with HIV: new interventions needed to save infants and to spare mothers.
HIV drug-resistant strains as epidemiologic sentinels.
Tuberculosis drug resistance and HIV infection, the Netherlands.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters